RETHINK: a cohort study to measure biomarker and psycho-social determinants that influence upper limb motor recovery in ischaemic stroke patients.

niversity of Technology Sydney0 个研究点目标入组 970 人开始时间: 2019年7月30日最近更新: 2019年8月26日

试验速览

暂无简介。

•Ischaemic stroke cases defined in consultation with specialist neurologist and based on routine care imaging (CT and/or MRI); greater than 18 years old and have persistent symptoms of any deficit for greater than 5-7 days. Stroke is defined by standard definitions and then stratified into groups according to domains of deficit. Each recovery domain will be defined by clinical symptom items as per National Institute of Health Stroke Scale (NIHSS). Parameters include deficit symptoms persisting for greater than 5-7 days.

•Severe illnesses i.e. palliative medical management in place, another neurological condition, seizure activity that prevent NIHSS assessment, patients unable to provide consent due to communication deficits or have no access to appropriate substitute decision maker, carer or in the case of non-English speaking case, a translator. For study subjects who agree to participate in the faecal microbiome arm, exclusion will include a history of inflammatory bowel disease or antibiotic use within 30 days of admission.

发起方

niversity of Technology Sydney